How have Twist Bioscience Corporation (TWST)’s performance and profitability changed over the time?

Twist Bioscience Corporation [TWST] stock is trading at $16.78, down -0.94%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TWST shares have lost -2.21% over the last week, with a monthly amount drifted -30.86%, and not seem to be holding up well over a long-time horizon.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


On 9, March 2023, Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches. In a post published today on Yahoo Finance, — Integrated offering to be highlighted at Festival of Biologics –.

From an analyst’s perspective:

Twist Bioscience Corporation [NASDAQ: TWST] stock has seen the most recent analyst activity on January 05, 2023, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $33. Previously, Evercore ISI upgraded its rating to Outperform on January 03, 2023, and elevated its price target to $36. William Blair initiated its recommendation with a Outperform. Goldman started tracking with a Neutral rating for this stock on June 04, 2021, and assigned it a price target of $110. In a note dated April 12, 2021, Piper Sandler initiated an Overweight rating and iterated a target price of $150 on this stock.

Twist Bioscience Corporation [TWST] stock has fluctuated between $14.98 and $58.76 over the past year. Twist Bioscience Corporation [NASDAQ: TWST] shares were valued at $16.78 at the most recent close of the market.

Analyzing the TWST fundamentals

Gross Margin for this corporation currently stands at +41.38% with Operating Margin at -122.33%, Pretax Margin comes in at -112.14%, and Net Margin reading is -107.02%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.34 points at the first support level, and at 15.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.15, and for the 2nd resistance point, it is at 17.53.

Twist Bioscience Corporation [TWST] reported earnings per share of -$0.74 for its fiscal quarter that ended on 12/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.13/share, meaning a difference of $0.39 and a surprise factor of 34.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2022 were -$0.91 per share as compared to estimates of -$1.25 per share, a difference of $0.34 representing a surprise of 27.20%.

Ratios To Look Out For

For context, Twist Bioscience Corporation’s Current Ratio is 6.50. Also, the Quick Ratio is 6.15, while the Cash Ratio stands at 5.57. Considering the valuation of this stock, the price to sales ratio is 9.33, the price to book ratio is 2.52.

Transactions by insiders

We now turn our attention to insider trading, which in the past 3 months has resulted in 15 insider buyings of 242,344 shares and 27 insider sellings of 14,725 shares. Recent insider trading involved Starovasnik Melissa A., Director, that happened on Feb 09 when 1732.0 shares were sold. Director, JOHANNESSEN JAN completed a deal on Feb 09 to sell 1732.0 shares. Meanwhile, Banyai William sold 292.0 shares on Jan 04.